An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer (AVF4349n)

Study identification

• EU PAS number:
  EUPAS3017
• Study ID:
  3018
• Official title and acronym:
  An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer (AVF4349n)
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study description:
  This is a multicenter, prospective OCS designed to follow patients with locally recurrent or metastatic breast cancer in the United States. Two cohorts will be included:- Patients with HER2-negative disease (as determined by the investigator) receiving their first cytotoxic chemotherapy and/or targeted therapy (approximately 825 patients)-Patients with HR-positive disease (as determined by the investigator) receiving their first HT for advanced disease (approximately 425 patients)
• Study status:
  Planned

Research institutions and networks

Institutions

Genentech

Study timelines

Date when funding contract was signed

Planned:02/06/2008

Study start date

Planned:02/06/2008

Date of final study report

Planned:01/04/2013

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Genentech Inc

Regulatory

• Was the study required by a regulatory body?:
  No